Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of levosimendan on systemic and splanchnic circulation in patients undergoing elective abdominal aortic aneurysm surgery
2004-002825-37Phase 4Completed
- Sponsor
- Taysha Gene Therapies
- Start
- Sep 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of levosimendan in abdominal aortic aneurysm (AAA), sponsored by Taysha Gene Therapies. Primary endpoint: Change in splanchnic blood flow with levosimendan. Started Sep 2004; status: completed.
02
Drugs
levosimendan
03
Conditions
abdominal aortic aneurysm (AAA)
Beyond the preview
Go deeper on 2004-002825-37.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-002825-37.